Skip to main content
Top
Published in: International Journal of Hematology 1/2004

01-07-2004

Clinical Relevance of Survivin as a Biomarker in Neoplasms, Especially in Adult T-Cell Leukemias and Acute Leukemias

Authors: Kazuyuki Sugahara, Akiko Uemura, Hitomi Harasawa, Hiroshi Nagai, Yoichi Hirakata, Masao Tomonaga, Kenn Murata, Hiroshi Sohda, Toru Nakagoe, Sin-ichi Shibasaki, Yasuaki Yamada, Shimeru Kamihira

Published in: International Journal of Hematology | Issue 1/2004

Login to get access
Metadata
Title
Clinical Relevance of Survivin as a Biomarker in Neoplasms, Especially in Adult T-Cell Leukemias and Acute Leukemias
Authors
Kazuyuki Sugahara
Akiko Uemura
Hitomi Harasawa
Hiroshi Nagai
Yoichi Hirakata
Masao Tomonaga
Kenn Murata
Hiroshi Sohda
Toru Nakagoe
Sin-ichi Shibasaki
Yasuaki Yamada
Shimeru Kamihira
Publication date
01-07-2004
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.04031

Other articles of this Issue 1/2004

International Journal of Hematology 1/2004 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine